BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4276607)

  • 1. Proceedings: Dose-dependence of chlorphentermine-induced ultrastructural alterations in rat.
    Lüllmann-Rauch R; Reil GH
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R60. PubMed ID: 4276607
    [No Abstract]   [Full Text] [Related]  

  • 2. [A massive appearance of "foam cells" in rat lungs following chronic administration of chlorphentermine].
    Franken G; Lüllmann H; Siegfriedt A
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):323-4. PubMed ID: 4253764
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced foam cell reactions in rats. I. Histopathologic and cytochemical observations after treatment with chlorphentermine, RMI 10.393 and Ro 4-4318.
    Karabelnik D; Zbinden G; Baumgartner E
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):395-407. PubMed ID: 4136644
    [No Abstract]   [Full Text] [Related]  

  • 4. [Appearance of abnormal macrophages in the alveoli of the rat following treatment with an appetite depressant (chlorphentermine)].
    Lüllmann-Rauch R; Rossen E; Seiler KU
    Verh Anat Ges; 1972; 67():205-9. PubMed ID: 4363835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F
    Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlorphentermine-induced ultrastructural alterations in foetal tissues.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol; 1973 Mar; 12(4):295-302. PubMed ID: 4350408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delayed effects of Avipron].
    Chojnowski JR; Adamska-Dyniewska H; Chojnowska-Jezierska J; Goch JH
    Wiad Lek; 1973 May; 26(10):907-12. PubMed ID: 4710730
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative ultrastructural study of the effects of chlorphentermine and triparanol in rat lung and adrenal gland.
    Lüllmann H; Lüllmann-Rauch R; Reil GH
    Virchows Arch B Cell Pathol; 1973 Jan; 12(2):91-103. PubMed ID: 4351712
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice.
    Abdallah AH
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on animal and organ specificity of chlorphentermine induced morphological alterations (author's transl)].
    Parwaresch R; Reil GH; Seiler KU
    Res Exp Med (Berl); 1973 Nov; 161(4):272-88. PubMed ID: 4358569
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between anorectic and reinforcing properties of appetite suppressant drugs: implications for assessment of abuse liability.
    Griffiths RR; Brady JV; Snell JD
    Biol Psychiatry; 1978 Apr; 13(2):283-90. PubMed ID: 96878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of fenfluramine, chlorphentermine, and related compounds on the behavior of aggressive mice].
    Weischer ML; Opitz K
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):252-9. PubMed ID: 5062780
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electroencephalography in the course of Avipron administration as an appetite depressant].
    Czarnecka E; Gawlik L
    Wiad Lek; 1974 Feb; 27(3):245-8. PubMed ID: 4839700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anorexigenic phenylalkylamines and serotonin metabolism].
    Opitz K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 259(1):58-65. PubMed ID: 4233263
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 16. NMR-studies on the molecular basis of drug-induced phospholipidosis. Interaction between chlorphentermine and phosphatidylcholine.
    Seydel JK; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(2):207-10. PubMed ID: 4272459
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies with the new appetite depressant N-(3-chlorpropyl)-1-methyl-2-phenylethylamine hydrochloride (Ro 4-5282)].
    Blum JE
    Arzneimittelforschung; 1969 May; 19(5):748-55. PubMed ID: 5819782
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics of phentermine and chlorphentermine in chronically treated rats.
    Lüllmann H; Rossen E; Seiler KU
    J Pharm Pharmacol; 1973 Mar; 25(3):239-43. PubMed ID: 4146324
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of anorexigenic and behavioral potency of phenylethylamines.
    Cox RH; Maickel RP
    J Pharmacol Exp Ther; 1972 Apr; 181(1):1-9. PubMed ID: 5066966
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine.
    Ross SB; Renyi AL; Ogren SO
    Eur J Pharmacol; 1972 Jan; 17(1):107-12. PubMed ID: 4536952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.